About James Ellis
James Ellis is a chief scientific officer at Nocion Therapeutics.
James Ellis first appears on SEC filings in 2021.
Experience
This experience comes from James Ellis's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Ellis in the role, so the role may have started earlier or lasted longer.
Nocion Therapeutics, Inc. Current
Chief Scientific Officer
CSO (2018 – Present)
2018 – Present · Watertown, MA
Develops inhaled medicines for people with chronic cough.
MB
Metro Biotech Current
Scientific Advisory Board Member
2017 – Present
GS
GSK
Vice President, Head Boston Innovation Hub
2017
GL
GlaxoSmithKline
Vice President, Head Sirtuin DPU
2013 – 2016
SC
Sirtris, a GSK Company
VP Preclinical Research
2008 – 2013
SL
Surface Logix
VP, Research
2006 – 2008
NI
NitroMed
Executive Director & Chief Biology Advisor
2003 – 2006
UP
UCB Pharma
Senior Director Pharmacology & Group Director Allergy & Respiratory
1996 – 2003
CI
CytoMed, Inc.
Sr Director
1996 – 1999
NP
Nova Pharmaceutical
Pharmacologist
1985 – 1988
Key Colleagues at Startups
The people James Ellis works with at each company, as listed on that company's latest Form D.
Nocion Therapeutics, Inc. · Form D, Mar 13, 2026
VM
Vijay Murthy
Director
JG
Julie Grant
Director
PO
Pini Orbach
Director
RH
Rosy Hu
Director
Matthew Frankel
Chief Medical Officer
Peter Courossi
Acting Chief Financial Officer
Richard Batycky
President and Chief Executive Officer, director
FD
Freddie Dear
Director
MH
Michael Higgins
Director